Interventional Cardiology sits at a distinctive boundary: it diagnoses through catheters and can then cross immediately into treatment without opening the chest.
That makes it more than a procedure list. It is a movement system connecting cardiovascular symptoms and disease to invasive measurement, anatomical definition, physiological assessment, catheter-based therapy, device implantation, reperfusion, haemodynamic change and long-term cardiovascular return.
Singapore’s National Heart Centre Singapore describes interventional cardiology as treating coronary artery disease through cardiac catheterisation, angioplasty, stenting and related procedures, while its Structural Heart Disease Programme extends catheter-based therapy to valve and other structural problems. The canonical public job is therefore:
cardiovascular problem → invasive or non-invasive evidence → coronary/structural target → catheter access → diagnostic measurement and/or intervention → restored flow or altered structure → device/procedure receipt → post-procedure care → secondary prevention and longitudinal function.
Wait, What? A Catheterisation Is Not Automatically an Angioplasty
Cardiac catheterisation can be diagnostic. Coronary angiography can show anatomy. Pressure wires and intravascular imaging can add physiological or structural information. Percutaneous coronary intervention (PCI) is a treatment procedure that may use balloons, stents or other devices. Structural heart interventions may target valves or septal defects.
For eduKateAI, the anti-collapse rule is essential: angiography ≠ PCI; coronary stenosis ≠ automatic stent; catheter procedure ≠ cardiac surgery; structural heart disease ≠ coronary artery disease.
The Interventional Cardiology Tube
Symptoms/risk/known disease → cardiovascular assessment → non-invasive and/or invasive evidence → define coronary or structural target → urgency and indication → vascular access → catheter navigation → imaging/pressure measurement → intervention if indicated → device or anatomical result → complications/haemostasis → post-procedure medication and monitoring → cardiac rehabilitation/secondary prevention → recurrence or surveillance.
1. The First Question Is What Problem Needs to Be Changed
Chest pain, heart attack, valve disease, congenital structural abnormalities or other cardiovascular states can lead to catheter-based evaluation. But the reason for intervention matters more than the presence of a catheter laboratory.
The Cardiovascular Medicine Web owns the broader disease trajectory. Interventional Cardiology receives the case when a lesion, obstruction, valve or structural target may benefit from a catheter-based procedure.
2. Coronary Angiography Defines the Road Map
Invasive coronary angiography uses contrast and X-ray imaging to show the coronary arteries. The result can identify narrowing, occlusion, vessel anatomy and relationships important for treatment planning.
But visual narrowing is only one part of the decision. Clinical presentation, symptoms, ECG, biomarkers, ventricular function, lesion physiology and the wider coronary pattern may all influence whether medicine, PCI or bypass surgery is most appropriate.
3. Heart Attack Turns the Tube Into an Emergency Route
When a coronary artery is acutely blocked during certain heart attacks, time becomes myocardium. NHCS currently provides round-the-clock acute angioplasty for appropriate heart-attack patients, reflecting the time-critical role of reperfusion.
The Emergency & Critical Care Web owns recognition and stabilisation. Interventional Cardiology owns the catheter-based restoration of coronary blood flow when indicated.
4. PCI Is a Sequence, Not a Single Object
PCI generally involves arterial access, guide catheters, passage of a wire across a coronary lesion, balloon treatment and often stent implantation. More complex disease may require additional technologies such as atherectomy, intravascular imaging or physiological measurement.
NHCS lists angioplasty, stent implantation, rotational atherectomy, intravascular ultrasound and pressure-wire measurement within its current invasive and interventional services.
5. A Stent Is an Implanted Medical Device With a Long Memory
A coronary stent remains in the artery after the procedure. That means the Medicine Web must preserve device identity, implant date, vessel/lesion, antiplatelet plan, adverse events and later procedures where relevant.
The Medical Devices, Implants & Post-Market Safety Web owns device identity and post-market safety. Interventional Cardiology owns why and where the cardiac device was implanted and how it affects subsequent cardiovascular care.
6. Opening an Artery Is Not the Same as Curing Atherosclerosis
PCI can restore blood flow through a specific lesion, but coronary artery disease is a systemic process. Smoking, blood pressure, lipids, diabetes, activity, diet, medicines and other factors remain important after a technically successful procedure.
This produces one of the most important anti-collapse rules in the entire cardiovascular web: stent success ≠ coronary disease cured.
7. Structural Heart Disease Is a Different Target Class
Not every catheter intervention is about coronary arteries. Structural heart disease includes abnormalities of valves, septa and other cardiac structures. NHCS currently provides transcatheter approaches for aortic, mitral and tricuspid valve disease as well as selected closure procedures.
For eduKateAI, the object should therefore be labelled precisely: coronary lesion, valve lesion, septal defect, appendage or another structural target. A generic “heart catheter procedure” loses the clinical job.
8. TAVI Changes a Valve Without Open-Heart Replacement
Transcatheter aortic valve implantation/replacement places a prosthetic valve through a catheter route for selected patients with aortic valve disease. It is one example of how interventional cardiology has expanded from coronary vessels into structural therapy.
The decision is multidisciplinary because anatomy, valve severity, surgical risk, vascular access, life expectancy, other disease and patient goals all matter. The existence of a transcatheter option does not automatically make it the best option for every patient.
9. Valve Intervention Needs Imaging Before, During and After
Structural heart procedures often depend heavily on echocardiography, CT and fluoroscopy. Imaging can define anatomy, guide device placement and assess the immediate result.
The Radiology & Imaging Web owns imaging principles. Interventional Cardiology owns the catheter-based treatment decision and procedure.
10. Electrophysiology Is a Neighbour, Not the Same Specialty Job
Some cardiac catheter procedures map electrical pathways and treat arrhythmias. Those are already owned by the Cardiac Electrophysiology & Rhythm Management Web.
This node instead owns coronary and structural catheter interventions. The shared location—the cath lab—does not mean shared canonical ownership.
11. The Access Site Is Part of the Procedure State
Catheter procedures generally enter through an artery or vein, commonly at the wrist or groin depending on the intervention. Access choice affects haemostasis, mobility, bleeding surveillance and some procedural risks.
For eduKateAI, the access route should remain explicit rather than disappearing after the procedure is complete.
12. Contrast, Radiation and Kidney State Cross Into Other Owners
Fluoroscopy uses ionising radiation, and iodinated contrast is commonly used in coronary procedures. Renal function, previous contrast reactions and other patient-specific considerations can change procedural planning.
These objects route outward to the Radiology & Imaging Web, Renal Medicine Web and Allergy & Clinical Immunology Web as appropriate.
13. Post-Procedure Medicines Are Part of the Intervention
After coronary stenting, antiplatelet therapy can be critical to prevent thrombotic complications. The exact regimen and duration depend on the clinical context, device, bleeding risk and current guidelines.
The Pharmacy Web owns the medicine object. Interventional Cardiology must pass forward why the medicine is required and which implanted device or coronary event it protects.
14. The Immediate Receipt Is Anatomical and Physiological
A successful coronary intervention may show restored flow and an acceptable angiographic result. A valve intervention may reduce a gradient or regurgitation. But these are intermediate receipts.
The human receipt arrives later: survival, freedom from recurrent ischaemia, symptom improvement, exercise capacity, reduced hospitalisation, return to work and quality of life.
15. Cardiac Rehabilitation and Prevention Complete the Tube
After myocardial infarction or PCI, recovery can include medication optimisation, risk-factor control, graded physical activity, cardiac rehabilitation and longitudinal follow-up. Revascularisation creates an opportunity; prevention determines much of the long-term trajectory.
The Sports & Exercise Medicine Web may own selected exercise-capacity questions, while the Cardiovascular and Primary Care routes own long-term disease control.
eduKateAI Interventional Cardiology Tube Card
- CLINICAL STATE: acute coronary syndrome, stable coronary disease, valve disease or another structural problem?
- TARGET: which vessel, lesion, valve or structure?
- URGENCY: emergency reperfusion or planned intervention?
- EVIDENCE: symptoms, ECG, biomarkers, echo, CT, angiography, physiological assessment?
- INDICATION: what outcome should intervention improve?
- ACCESS: arterial or venous route, and where?
- PROCEDURE: angiography, PCI, stent, atherectomy, valve intervention, closure or another therapy?
- DEVICE: what was implanted, where and when?
- SAFETY: bleeding, vascular injury, contrast, renal state, radiation, rhythm or haemodynamic risk?
- MEDICINES: what post-procedure therapy protects the result?
- IMMEDIATE RECEIPT: flow, gradient, valve function, haemostasis and complications.
- HUMAN RETURN: symptoms, exercise capacity, recurrent events, rehabilitation and long-term cardiovascular risk.
Canonical External Sources
- Singapore interventional cardiology: National Heart Centre Singapore Interventional Cardiology.
- Structural heart therapy: NHCS Structural Heart Disease Programme.
- PCI outcomes and current service context: NHCS Percutaneous Coronary Intervention clinical outcomes.
- Acute coronary and cardiovascular evidence: current national and international cardiology guidelines.
- Devices and medicines: current regulators, device information and pharmacotherapy guidance.
Movement to the Next Nodes
- Whole cardiovascular disease trajectory? → Cardiovascular Medicine Web.
- Electrical rhythm intervention? → Cardiac Electrophysiology Web.
- Cardiac device identity or recall? → Medical Devices & Implants Web.
- Medication management? → Pharmacy Web.
- Need the whole architecture? → Medicine Web Master Map.
Educational boundary: This page explains interventional-cardiology information architecture. It does not diagnose coronary or valve disease, decide whether an individual needs angiography, PCI, a stent or structural-heart intervention, determine antiplatelet treatment or replace qualified cardiovascular and emergency care.